Claims
- 1. A compound of Formula I
- 2. A compound of claim 1 in which R1 is —(CH2)mZ—R; m is 0, Z is —CH2— and R is selected from the group consisting of:
- 3. The compound of claim 1 which is 8-(benzylamino-methyl)-3,5,7,8-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]naphthalen-2-one or a pharmaceutically acceptable salt thereof.
- 4. A pharmaceutical composition comprising a compound of Formula (I):
- 5. A method for treating diseases of brain dopamine dysregulation, which comprises administering to a subject in need thereof an effective amount of a compound of Formula I
- 6. The method of claim 5 wherein the disease of brain dopamine dysregulation is schizophrenia, Parkinson's disease, hyperprolactinemia, depression or Tourette's syndrome.
- 7. The method of claim 6 wherein the disease of brain dopamine dysregulation is schizophrenia.
- 8. The method of claim 7 wherein the disease of brain dopamine dysregulation is alcohol or drug addiction.
Parent Case Info
[0001] This application claims priority from copending provisional application Serial No. 60/306,930, filed Jul. 20, 2001, the entire disclosure of which is hereby incorporated by reference.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60306930 |
Jul 2001 |
US |